Mexico/Grants Emergency Use of Russia Vaccine to Fight Coronavirus
Mexico regulatory agency grants emergency authorization of/Russian Sputnik V vaccine as it prepares to launch vaccination program ///Actualités similaires
Articles similaires à Mexico/Grants Emergency Use of Russia Vaccine to Fight Coronavirus
New York State to Resume Use of Johnson & Johnson COVID Vaccine
New York Governor Cuomo announces move despite evidence that the vaccine has been found to be linked to rare cases of blood clotsActualités similaires
Mexico Receives First Shipment of Russian Vaccine to Fight COVID-19
Mexico's foreign minister receives first shipment of Russian Sputnik V vaccine against COVID-19 //South Korea Grants Emergency Use of Controversial AstraZeneca Vaccine/
Vaccine developed jointly with Oxford University has been limited due to lack of data on efficacy among elderly ////Actualités similaires
Mexico/Grants Emergency Use of Russia Vaccine to Fight Coronavirus
Mexico regulatory agency grants emergency authorization of/Russian Sputnik V vaccine as it prepares to launch vaccination program ///Actualités similaires
Chile Approves Emergency Use of Second Coronavirus Vaccine
Chile set to use CoronaVac vaccine made by China's Sinovac Biotech Ltd.Actualités similaires
Mexico Grants Emergency Approval to AstraZeneca-Oxford Coronavirus Vaccine
Mexico joins Britain, India and Argentina to formally approve vaccine far easier to store at normal temperatures and transport to poorer nationsActualités similaires
WHO Approves Emergency Use of Pfizer Vaccine
Also, China approves for use a vaccine by Sinopharm, which says it is 79% effective against coronavirus ////US Approves Coronavirus Vaccine for Emergency Use
Trump Hails Approved Coronavirus Vaccine as Medical Miracle'Actualités similaires
Canada Latest Nation to Approve Pfizer/BioNTech Vaccine for Emergency Use
Prime minister expects first doses to arrive next weekActualités similaires
Britain Warns People with History of Allergic Reactions Not to Get Coronavirus Vaccine
Warning comes after two people had adverse reactions to vaccine on first day of rollout in BritainActualités similaires
Britain Approves Pfizer Coronavirus Vaccine, Raising Hopes of Return to Normality
Poorer health systems may struggle to roll out the Pfizer-BioNTech vaccineActualités similaires
Britain Grants Emergency Approval of New COVID-19 Vaccine/Developed by U.S.-Based Pfizer and Germany's BioNTech
'Historic moment' makes Britain first Western nation preparing to begin mass inoculations against novel coronavirusActualités similaires
Moderna to Seek Quick Approval of Coronavirus Vaccine in US, Europe
US biotechnology company's request could mean that health workers will be able to inoculate patients against virus as soon as mid-DecemberActualités similaires
Experts Warn of China's Emergency Use of COVID-19 Vaccine
China in recent months has been injecting hundreds of thousands of people with three preliminary coronavirus vaccines that are being tested for safety and ...Actualités similaires
Russia Accused of Trying to Steal COVID-19 Vaccine Information
Accusations made by Britain, Canada and the USActualités similaires
US Revokes Emergency Use of Malaria Drugs Vs. Coronavirus
The Food and Drug Administration said that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirusActualités similaires
US Sends 2 Million Doses of Hydroxychloroquine to Brazil to Fight Coronavirus
The US has 1.7 million cases while Brazil, which is emerging as the world's hotspot for the virus, has more than 514,000, according to Johns Hopkins UniversityActualités similaires
Japan to Lift Coronavirus State of Emergency for Tokyo
Tokyo to emerge from emergency decree imposed on April 7 due to apparent easing of COVID-19 outbreakActualités similaires
EU Eyes Mobilization of Retired Medical Workers, Students to Fight Coronavirus
More than 4,000 cases have been so far detected across EU countries, with many facing shortages in skilled staffActualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
